Australia markets close in 4 hours 33 minutes

Lyra Therapeutics, Inc. (LYRA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.2580-0.0047 (-1.79%)
At close: 04:00PM EDT
0.2580 0.00 (0.00%)
After hours: 07:54PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 16.25M
Enterprise value -33.00M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)8.98
Price/book (mrq)0.21
Enterprise value/revenue -21.80
Enterprise value/EBITDA 0.66

Trading information

Stock price history

Beta (5Y monthly) 0.02
52-week change 3-93.60%
S&P500 52-week change 324.43%
52-week high 36.7900
52-week low 30.2560
50-day moving average 31.8545
200-day moving average 33.8283

Share statistics

Avg vol (3-month) 33.56M
Avg vol (10-day) 31.47M
Shares outstanding 560.96M
Implied shares outstanding 660.96M
Float 837.64M
% held by insiders 10.70%
% held by institutions 188.12%
Shares short (15 May 2024) 4603.03k
Short ratio (15 May 2024) 40.09
Short % of float (15 May 2024) 41.26%
Short % of shares outstanding (15 May 2024) 40.99%
Shares short (prior month 15 Apr 2024) 4333.56k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-4,421.81%

Management effectiveness

Return on assets (ttm)-38.10%
Return on equity (ttm)-95.93%

Income statement

Revenue (ttm)1.68M
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)29.80%
Gross profit (ttm)N/A
EBITDA -71.61M
Net income avi to common (ttm)-68.88M
Diluted EPS (ttm)-1.1700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)87.12M
Total cash per share (mrq)1.43
Total debt (mrq)37.86M
Total debt/equity (mrq)48.85%
Current ratio (mrq)4.78
Book value per share (mrq)1.27

Cash flow statement

Operating cash flow (ttm)-69.91M
Levered free cash flow (ttm)-39.69M